News

Senate Republicans remain wary of eliminating the popular and successful global HIV/AIDS program PEPFAR, as they face down a ...
Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...
In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...
FRIDAY, July 11, 2025 (HealthDay News) — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, ...
There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...
Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...
Two New Zealand babies have been diagnosed with HIV passed on from their mothers for the first time in nearly 20 years. Perinatal HIV cases were effectively eliminated in New Zealand in 2007 after ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Global HIV program a ...
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...
Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...